Jing Ren

1.7k total citations
60 papers, 1.4k citations indexed

About

Jing Ren is a scholar working on Molecular Biology, Genetics and Oncology. According to data from OpenAlex, Jing Ren has authored 60 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Molecular Biology, 10 papers in Genetics and 10 papers in Oncology. Recurrent topics in Jing Ren's work include Glioma Diagnosis and Treatment (8 papers), Immune cells in cancer (5 papers) and Natural product bioactivities and synthesis (4 papers). Jing Ren is often cited by papers focused on Glioma Diagnosis and Treatment (8 papers), Immune cells in cancer (5 papers) and Natural product bioactivities and synthesis (4 papers). Jing Ren collaborates with scholars based in China, United States and Macao. Jing Ren's co-authors include Xiuying Pu, Jiawei Li, Dereje Kebebe, Yuanyuan Liu, Bing Zhang, Yumei Wu, Yibo Du, Guoguang Ying, Yan Zhao and Shuangshuang Du and has published in prestigious journals such as Journal of Agricultural and Food Chemistry, Scientific Reports and Spine.

In The Last Decade

Jing Ren

58 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jing Ren China 18 511 247 167 166 153 60 1.4k
Hongyi Qi China 28 873 1.7× 144 0.6× 158 0.9× 277 1.7× 197 1.3× 66 2.0k
Hyun‐Joo Jung South Korea 21 743 1.5× 275 1.1× 218 1.3× 129 0.8× 39 0.3× 47 1.6k
Nu‐Man Tsai Taiwan 22 671 1.3× 125 0.5× 116 0.7× 55 0.3× 53 0.3× 76 1.5k
Yongmei Guan China 20 386 0.8× 99 0.4× 89 0.5× 107 0.6× 61 0.4× 94 1.2k
Yuanyuan Guan China 24 705 1.4× 112 0.5× 154 0.9× 64 0.4× 94 0.6× 46 1.6k
Jian Hou China 25 764 1.5× 142 0.6× 108 0.6× 101 0.6× 33 0.2× 92 1.7k
Bing Han China 25 563 1.1× 242 1.0× 92 0.6× 78 0.5× 42 0.3× 78 1.6k
Syed Shadab Raza India 31 1.0k 2.0× 302 1.2× 268 1.6× 140 0.8× 33 0.2× 78 2.9k
Huali Chen China 21 778 1.5× 85 0.3× 53 0.3× 109 0.7× 193 1.3× 43 1.6k
Danshen Zhang China 15 653 1.3× 311 1.3× 188 1.1× 39 0.2× 44 0.3× 50 1.6k

Countries citing papers authored by Jing Ren

Since Specialization
Citations

This map shows the geographic impact of Jing Ren's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jing Ren with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jing Ren more than expected).

Fields of papers citing papers by Jing Ren

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jing Ren. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jing Ren. The network helps show where Jing Ren may publish in the future.

Co-authorship network of co-authors of Jing Ren

This figure shows the co-authorship network connecting the top 25 collaborators of Jing Ren. A scholar is included among the top collaborators of Jing Ren based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jing Ren. Jing Ren is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhao, Wen‐Yu, Lejun Zhang, Biao Xu, et al.. (2025). Centromere protein U mediates the ubiquitination and degradation of RPS3 to facilitate temozolomide resistance in glioblastoma. Drug Resistance Updates. 80. 101214–101214. 10 indexed citations
3.
Yang, Tao, Caigui Xiang, Xiaohan Wang, et al.. (2024). RIPK1 inhibitor ameliorates pulmonary injury by modulating the function of neutrophils and vascular endothelial cells. Cell Death Discovery. 10(1). 152–152. 13 indexed citations
4.
Wu, Sicheng, et al.. (2024). MAPK-activated protein kinase 2 is associated with poor prognosis of glioma patients and immune inhibition in glioma. Frontiers in Oncology. 14. 1307992–1307992. 1 indexed citations
5.
Luo, Haiqing, Yumeng Huang, Jing Li, et al.. (2022). DHA inhibits invasion and metastasis in NSCLC cells by interfering with CCL18/STAT3 signaling pathway. Clinical and Experimental Medicine. 23(6). 2311–2320. 6 indexed citations
6.
Ren, Jing, et al.. (2021). MAPK Activated Protein Kinase 3 Is a Prognostic-Related Biomarker and Associated With Immune Infiltrates in Glioma. Frontiers in Oncology. 11. 793025–793025. 3 indexed citations
7.
Wang, Xiang, et al.. (2021). Structure-guided discovery of novel potent and efficacious proteolysis targeting chimera (PROTAC) degrader of BRD4. Bioorganic Chemistry. 115. 105238–105238. 14 indexed citations
8.
Ren, Jing, Jing Xiang, Yueqiu Chen, et al.. (2019). Abnormal functional connectivity under somatosensory stimulation in migraine: a multi-frequency magnetoencephalography study. The Journal of Headache and Pain. 20(1). 3–3. 22 indexed citations
9.
Shi, Yao, Jing Ren, Xuejiao Song, et al.. (2019). Synthesis and biological evaluation of (1,2,4)triazole[4,3-a]pyridine derivatives as potential therapeutic agents for concanavalin A-induced hepatitis. European Journal of Medicinal Chemistry. 179. 182–195. 10 indexed citations
10.
Li, Yi, Xuecong Ren, Yuan Liu, et al.. (2018). A chlorogenic acid-phospholipid complex ameliorates post-myocardial infarction inflammatory response mediated by mitochondrial reactive oxygen species in SAMP8 mice. Pharmacological Research. 130. 110–122. 41 indexed citations
11.
Li, Jing, et al.. (2016). A comparative systematic review of Yasmin (drospirenone pill) versus standard treatment options for symptoms of polycystic ovary syndrome. European Journal of Obstetrics & Gynecology and Reproductive Biology. 210. 13–21. 10 indexed citations
12.
Feng, Yan, Yinghua Yu, Shuting Wang, et al.. (2016). Chlorogenic acid protects d-galactose-induced liver and kidney injury via antioxidation and anti-inflammation effects in mice. Pharmaceutical Biology. 54(6). 1027–1034. 111 indexed citations
13.
Ji, Juan, Yufeng Qin, Jing Ren, et al.. (2015). Mitochondria-related miR-141-3p contributes to mitochondrial dysfunction in HFD-induced obesity by inhibiting PTEN. Scientific Reports. 5(1). 16262–16262. 57 indexed citations
14.
Ren, Jing, et al.. (2015). Effect of luteolin on gene expression in mouse H22 hepatoma cells. Genetics and Molecular Research. 14(4). 14448–14456. 14 indexed citations
15.
Ma, Jinan, Chunhong Hu, Wenjuan Li, et al.. (2014). Downregulation of c-Met expression does not enhance the sensitivity of gastric cancer cell line MKN-45 to gefitinib. Molecular Medicine Reports. 11(3). 2269–2275. 6 indexed citations
16.
Song, Fenglin, Yanna Zhu, Xiujuan Deng, et al.. (2014). Plant food anthocyanins inhibit platelet granule secretion in hypercholesterolaemia: Involving the signalling pathway of PI3K–Akt. Thrombosis and Haemostasis. 112(11). 981–991. 54 indexed citations
17.
Chee, Ana, Jing Ren, Brett A. Lenart, et al.. (2013). Cytotoxicity of local anesthetics and nonionic contrast agents on bovine intervertebral disc cells cultured in a three-dimensional culture system. The Spine Journal. 14(3). 491–498. 29 indexed citations
18.
Zhang, Yejia, Brett A. Lenart, Joseph K. Lee, et al.. (2013). Histological Features of Endplates of the Mammalian Spine. Spine. 39(5). E312–E317. 39 indexed citations
19.
Wang, Jing, Xiujie Wang, Shu Jiang, et al.. (2008). Partial Biological Characterization of Cancer Stem-like Cell Line (WJ2) of Human Glioblastoma Multiforme. Cellular and Molecular Neurobiology. 28(7). 991–1003. 15 indexed citations
20.
Sun, Lixin, Wenwei Fu, Jing Ren, et al.. (2006). Cytotoxic constituents fromSolanum lyratum. Archives of Pharmacal Research. 29(2). 135–139. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026